Treatment Registry
TR-0717 ActiveRecorded September 2026Last verified October 2026

Compounded tirzepatide

Sold by Luci · Oral tablet · every compounded tirzepatide record

Price

TermPublished rateCharged today
Advertised starting amount on annual prepaid plan; price basis unresolved

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$145”

$145Published figureCharged todayNot verified
Price sources
Visit Luci

We earn nothing from this link. It opens Luci's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNetwork: EPIQ; Emerald; Striker (assignment varies)
StatesNot disclosed
PrescriberNot disclosed
CancellationThe terms require cancellation at least three days before processing and permit charging or shipping three days early. They generally exclude partial-period refunds. A separate GLP-1 policy describes a conditional six-month guarantee with adherence, weight-recording, starting BMI and request-window requirements; it also describes refunds for initial medical ineligibility and a prorated remedy for unresolved side effects. Confirm which policy applies to the purchased plan.
MembershipNot disclosed
Consult fee$0, included in program price. The product page includes a no-cost consultation and ongoing support.

Recorded from lucirx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — States field intentionally left not-found rather than 'listed': the only explicit state statement found is an EXCLUSION list (8 states/DC not served), not a coverage list -- recording it as coverage would invert the claim. The Terms & Conditions page states in all caps 'ANY APPLICABLE FEES AND OTHER CHARGES ARE NOT REFUNDABLE IN WHOLE OR IN PART' (a 'NO REFUND POLICY'), which directly contradicts the separate /refund-policy page's advertised '6-month money-back guarantee' on GLP-1 treatments -- a real contradiction between the site's own two legal pages. The Terms page also refers to the company operating 'www.lucidirect.com' rather than lucirx.com, though lucirx.com's own header/footer consistently say 'Luci.'
  2. 2. October 2026 — Luci advertises a twelve-month prepaid oral program, showing a starting amount without a clear price basis or an exact total invoice in the reviewed page. Its standard cancellation terms differ from the separate conditional refund guarantee. The FAQ names EPIQ, Emerald and Striker in its pharmacy network, but the assigned pharmacy is not established. Its all-50-state FAQ conflicts with a footer describing selected states. The pages also contain inconsistent brand and clinical-network names, so confirm eligibility and the contracting service before enrollment.

1 further note concerns other Luci programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0717
Medication category
compounded tirzepatide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). Luci — compounded tirzepatide (TR-0717). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0717

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.